| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,371 | 16,300 | 22,040 | 26,036 | | Cost of Revenue | 16,686 | 14,633 | 16,678 | 17,924 | | | Gross Profit | 2,685 | 1,667 | 5,362 | 8,112 | | | Operating Expenses | | Research Development | 1,013 | 1,691 | 977 | 2,057 | | Selling General and Administrative | 5,187 | 11,761 | 6,997 | 7,250 | | Non Recurring |
-
| (5,830) | 5,830 |
-
| | Others | 320 | 339 | 575 | 338 | | | | Total Operating Expenses |
-
| 7,961 | 14,379 |
-
| | | | Operating Income or Loss | (3,835) | (6,294) | (9,017) | (1,533) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 430 | (468) | (1,394) |
-
| | Earnings Before Interest And Taxes | (5,755) | (6,574) | (10,411) | (1,685) | | Interest Expense | (654) | 376 | 278 | 291 | | Income Before Tax | (5,101) | (6,950) | (10,689) | (1,976) | | Income Tax Expense |
-
|
-
| 2 | 1 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,429) | (6,950) | (10,691) | (1,977) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,101) | (6,950) | (10,691) | (1,977) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,101) | ($6,950) | ($10,691) | ($1,977) |
|
0.51% Nasdaq 0.00%
Income Statement
